Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • n2hasan
    Junior Member
    • Sep 2009
    • 6

    #1

    Greetings

    Hello,

    My name is Nabeeh. I am one of two graduate research assistants working with the newly acquired Roche 454-FLX and lightcycler for our Biology Department at New Mexico State University.

    We are interested in both bioinformatic development, refining and innovating wet lab protocols for the 454. Thus far, we are having issues with: i)system stability, one co-PI has his cluster setup on netBSD which seems to be problematic with the latest 454 software update (the system crashed during our last run analysis/assembly); ii) issues of how to take the sequence output and get the sequence assembly data into GFF(3) format for a CHADO schema seems nontrivial without a formal protocol or prevalent approach existing; iii)the latest chemistry seems to have effected the bead recovery during sequencing.

    So I hope that the community here is supportive and becomes a tremendous resource for upstarts like ourselves down here in Las Cruces, NM.

    Best Regards,

    Nabeeh Hasan
    Graduate Assistant, II
    Department of Biology
    New Mexico State University

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 10:35 AM
0 responses
7 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-06-2026, 07:41 AM
0 responses
24 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-03-2026, 10:13 AM
0 responses
43 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-31-2026, 02:55 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...